EU Medicines Agency

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

EU Medicines Agency

Nov 6, 2024, 13:15 | Blog

Michael T. McCarthy: A case study of Anti-Cancer Drug reimbursement in Ireland

Michael T. McCarthy posted on X: "A case study of Anti-Cancer Drug reimbursement in Ireland…

Jul 20, 2024, 12:13 | Blog

The speakers of ECO's next Protect Europe masterclass

European Cancer Organisation shared a post on X: ''Meet the speakers of our next Protect…

Jun 16, 2024, 17:20 | Insight

Yvonne Diaz: EU Medicines Agency has approved Alecensa (alectinib) for early stage stage ALK+ lung cancer

Yvonne Diaz, Co-founder of Oncogene Cancer Research, shared a post on X: “Great to see that…

May 3, 2024, 11:26 | Blog

Ben Westphalen: The 2nd tumour agnostic, biomarker-driven approval in the EU

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared a post…

Feb 14, 2024, 06:32 | Insight

Amol Akhade: What is the approach of Indian Oncologist Towards Drug approval agencies?

Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared on X/Twitter: "What is the…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023